<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.1d3" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLOS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pone.0193646</article-id>
<article-id pub-id-type="publisher-id">PONE-D-17-31543</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical microbiology</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Bacterial pathogens</subject><subj-group><subject>Helicobacter pylori</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Bacterial pathogens</subject><subj-group><subject>Helicobacter pylori</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Bacteria</subject><subj-group><subject>Helicobacter</subject><subj-group><subject>Helicobacter pylori</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Vascular medicine</subject><subj-group><subject>Atherosclerosis</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Cardiovascular anatomy</subject><subj-group><subject>Blood vessels</subject><subj-group><subject>Arteries</subject><subj-group><subject>Coronary arteries</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Cardiovascular anatomy</subject><subj-group><subject>Blood vessels</subject><subj-group><subject>Arteries</subject><subj-group><subject>Coronary arteries</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Diagnostic medicine</subject><subj-group><subject>Signs and symptoms</subject><subj-group><subject>Stenosis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Signs and symptoms</subject><subj-group><subject>Stenosis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Cardiovascular medicine</subject><subj-group><subject>Cardiovascular diseases</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Vascular medicine</subject><subj-group><subject>Coronary heart disease</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Cardiology</subject><subj-group><subject>Coronary heart disease</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Infectious diseases</subject><subj-group><subject>Bacterial diseases</subject><subj-group><subject>Helicobacter pylori infection</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Serology</subject></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Current <italic>Helicobacter pylori</italic> infection is significantly associated with subclinical coronary atherosclerosis in healthy subjects: A cross-sectional study</article-title>
<alt-title alt-title-type="running-head"><italic>Helicobacter</italic> and subclinical atherosclerosis</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<name name-style="western">
<surname>Lee</surname>
<given-names>Minyoung</given-names>
</name>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<name name-style="western">
<surname>Baek</surname>
<given-names>Haeri</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Park</surname>
<given-names>Jong Suk</given-names>
</name>
<role content-type="http://credit.casrai.org/">Resources</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Kim</surname>
<given-names>Sohee</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<xref ref-type="aff" rid="aff004"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Kyung</surname>
<given-names>Chanhee</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff005"><sup>5</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Baik</surname>
<given-names>Su Jung</given-names>
</name>
<role content-type="http://credit.casrai.org/">Methodology</role>
<xref ref-type="aff" rid="aff006"><sup>6</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Lee</surname>
<given-names>Byoung Kwon</given-names>
</name>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff007"><sup>7</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Kim</surname>
<given-names>Jie-Hyun</given-names>
</name>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff008"><sup>8</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Ahn</surname>
<given-names>Chul Woo</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Resources</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Kim</surname>
<given-names>Kyung Rae</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Resources</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-9719-4774</contrib-id>
<name name-style="western">
<surname>Kang</surname>
<given-names>Shinae</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Funding acquisition</role>
<role content-type="http://credit.casrai.org/">Project administration</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Division of Endocrinology, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Department of Internal Medicine, H-plus Yangji General Hospital, Seoul, Korea</addr-line></aff>
<aff id="aff003"><label>3</label> <addr-line>Severance Institute for Vascular and Metabolic Research, Yonsei University College of Medicine, Seoul, Korea</addr-line></aff>
<aff id="aff004"><label>4</label> <addr-line>Aswell convalescent hospital, Gwangju, Korea</addr-line></aff>
<aff id="aff005"><label>5</label> <addr-line>Rhin Hospital, Gyeonggi-do, Korea</addr-line></aff>
<aff id="aff006"><label>6</label> <addr-line>Healthcare Research Team, Health Promotion Center, Gangnam Severance Hospital, Seoul, Korea</addr-line></aff>
<aff id="aff007"><label>7</label> <addr-line>Division of Cardiology, Department of Internal Medicine Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea</addr-line></aff>
<aff id="aff008"><label>8</label> <addr-line>Division of Gastroenterology, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Green</surname>
<given-names>John</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>University Hospital Llandough, UNITED KINGDOM</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">shinae95@yuhs.ac</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>2</day>
<month>3</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>13</volume>
<issue>3</issue>
<elocation-id>e0193646</elocation-id>
<history>
<date date-type="received">
<day>28</day>
<month>8</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>15</day>
<month>2</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-year>2018</copyright-year>
<copyright-holder>Lee et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pone.0193646"/>
<abstract>
<p><italic>Helicobacter pylori</italic> is a gastrointestinal pathogen known to be associated with cardiovascular disease (CVD). However, most analyses about the effect of <italic>H</italic>. <italic>pylori</italic> infection have been done in patients with a history of CVD but not in healthy subjects. We evaluated the association between <italic>H</italic>. <italic>pylori</italic> infection and subclinical atherosclerosis by using cardiac multidetector computed tomography (MDCT) in healthy subjects without previous CVD. From December 2007 to February 2014, 463 subjects who underwent the rapid urease test (CLO test), pulse-wave velocity (PWV) measurement, and MDCT for a self-referred health check-up were enrolled to this study. <italic>Helicobacter pylori</italic> infection was defined on the basis of CLO test positivity on endoscopic gastric biopsy. Significant coronary artery stenosis was defined as ≥50% stenosis in any of the major epicardial coronary vessel on MDCT. The CLO-positive subjects had a lower high-density lipoprotein-cholesterol (HDL-cholesterol) level compared to the CLO-negative subjects. The incidence of significant coronary stenosis was higher in the CLO-positive group (7.6% vs. 2.9%, <italic>P</italic> = 0.01). Furthermore, the number of subjects with coronary artery calcium score &gt;0 and log{(number of segments with plaque)+1} were also significantly higher in the CLO-positive group. However, there was no statistical difference in the number of subjects with coronary artery calcium score &gt;100, the prevalence of any plaque nor the plaque characteristics (calcified, mixed, or soft). Pulse-wave velocity (PWV) was neither associated with CLO test positivity. The CLO-positive group was 3-fold more likely to have significant coronary artery stenosis even after adjusting for confounding factors (adjusted odds ratio 2.813, 95% confidence interval 1.051–7.528, <italic>P</italic> = 0.04). In a healthy population, current <italic>H</italic>. <italic>pylori</italic> infection was associated with subclinical but significant coronary artery stenosis. The causal relationship between <italic>H</italic>. <italic>pylori</italic> infection and subclinical atherosclerosis in a “healthy” population remains to be investigated in the future.</p>
</abstract>
<funding-group>
<award-group id="award001">
<funding-source>
<institution>Korea government Ministry of Science (MSIP)</institution>
</funding-source>
<award-id>2014R1A1A3051221</award-id>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-9719-4774</contrib-id>
<name name-style="western">
<surname>Kang</surname>
<given-names>Shinae</given-names>
</name>
</principal-award-recipient>
</award-group>
<funding-statement>This work was supported by the National Research Foundation of Korea (NRF, <ext-link ext-link-type="uri" xlink:href="http://www.nrf.re.kr" xlink:type="simple">http://www.nrf.re.kr</ext-link>) grant funded by the Korea government Ministry of Science (MSIP) (No. 2014R1A1A3051221). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
<counts>
<fig-count count="2"/>
<table-count count="3"/>
<page-count count="13"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec001" sec-type="intro">
<title>Introduction</title>
<p>Several studies have reported that cardiovascular disease (CVD) may be associated with certain microorganisms such as <italic>Chlamydia pneumonia</italic>, cytomegalovirus, or <italic>Helicobacter pylori</italic> [<xref ref-type="bibr" rid="pone.0193646.ref001">1</xref>]. Those reports have suggested that the pathogens might directly invade the vessel wall, leading to localized vascular inflammation [<xref ref-type="bibr" rid="pone.0193646.ref002">2</xref>]. Additionally, not only localized but also systemic inflammation by such pathogens might indirectly induce endothelial dysfunction and dyslipidemia, resulting in CVD [<xref ref-type="bibr" rid="pone.0193646.ref003">3</xref>].</p>
<p><italic>Helicobacter pylori</italic> is a gram-negative bacterium that lives in the stomach and a carcinogen leading to stomach cancer [<xref ref-type="bibr" rid="pone.0193646.ref004">4</xref>,<xref ref-type="bibr" rid="pone.0193646.ref005">5</xref>]. The infection rate of <italic>H</italic>. <italic>pylori</italic> is especially high in Asians [<xref ref-type="bibr" rid="pone.0193646.ref006">6</xref>]. Because local and systemic inflammation by microbes and infectious agents is known to be crucial in CVD [<xref ref-type="bibr" rid="pone.0193646.ref007">7</xref>,<xref ref-type="bibr" rid="pone.0193646.ref008">8</xref>], the relationship between <italic>H</italic>. <italic>pylori</italic> infection and CVD has received considerable attention especially in Asian countries [<xref ref-type="bibr" rid="pone.0193646.ref009">9</xref>–<xref ref-type="bibr" rid="pone.0193646.ref012">12</xref>].</p>
<p><italic>H</italic>. <italic>pylori</italic> has been suggested as a possible contributor to CVD progression but the results from the previous studies were quite controversial. Some reports showed that the seroprevalence of <italic>H</italic>. <italic>pylori</italic> was not correlated with coronary artery disease and they insisted that the infection status of <italic>H</italic>. <italic>pylori</italic> did not determine the risk of CVD [<xref ref-type="bibr" rid="pone.0193646.ref013">13</xref>–<xref ref-type="bibr" rid="pone.0193646.ref016">16</xref>]. In contrast, other reports demonstrated a meaningful higher prevalence of <italic>H</italic>. <italic>pylori</italic> infection among patients with previous history of CVD and supported a possible connection between <italic>H</italic>. <italic>pylori</italic> and the development of CVD [<xref ref-type="bibr" rid="pone.0193646.ref012">12</xref>,<xref ref-type="bibr" rid="pone.0193646.ref017">17</xref>–<xref ref-type="bibr" rid="pone.0193646.ref021">21</xref>]. In healthy populations without previous CVD, however, it still remains unclear whether <italic>H</italic>. <italic>pylori</italic> infection is significantly associated with subclinical atherosclerosis. The individuals with subclinical atherosclerosis are at a higher risk of developing clinical atherosclerosis including coronary heart disease compared to the individuals without subclinical diseases [<xref ref-type="bibr" rid="pone.0193646.ref022">22</xref>–<xref ref-type="bibr" rid="pone.0193646.ref024">24</xref>]. If the association between <italic>H</italic>. <italic>pylori</italic> and subclinical atherosclerosis is significant, earlier diagnosis and possibly eradication of <italic>H</italic>. <italic>pylori</italic> might be necessary for preventing atherosclerosis progression, especially in the high-risk population. Additionally, most studies on <italic>H</italic>. <italic>pylori</italic> infection and CVD have relied on antibody tests for defining the <italic>H</italic>. <italic>pylori</italic> infection status [<xref ref-type="bibr" rid="pone.0193646.ref017">17</xref>,<xref ref-type="bibr" rid="pone.0193646.ref018">18</xref>,<xref ref-type="bibr" rid="pone.0193646.ref020">20</xref>], the results of which cannot differentiate between current versus past infections. Additionally, tests using the serum antibodies demonstrate lower specificity than that of the rapid urease test (CLO test) [<xref ref-type="bibr" rid="pone.0193646.ref025">25</xref>,<xref ref-type="bibr" rid="pone.0193646.ref026">26</xref>].</p>
<p>In this study, we aimed to evaluate whether current <italic>H</italic>. <italic>pylori</italic> infection, diagnosed by using an endoscopic CLO test, was associated with subclinical atherosclerosis using pulse-wave velocity (PWV) and cardiac multidetector computed tomography (MDCT) in a healthy population.</p>
</sec>
<sec id="sec002" sec-type="materials|methods">
<title>Methods</title>
<sec id="sec003">
<title>Study design and population</title>
<p>This study included 527 consecutive subjects undergoing esophagogastroduodenoscopy with the CLO test, PWV, and MDCT as part of the self-referred health check-up program at Gangnam Severance Hospital Health Promotion Center, Seoul, Korea from December 2007 to February 2014. All participants were divided into two study groups according to the CLO positivity. To avoid confounding bias, we excluded possible confounding medical conditions known to be associated with the health outcome. The exclusion criteria were as follows: (i) history of coronary artery disease, (ii) significant hypothyroidism/hyperthyroidism (thyroid-stimulating hormone &gt;4.5 μIU/mL or free thyroxine &gt;2.0 ng/dL), (iii) significant renal insufficiency (creatinine &gt;1.5 mg/dL), (iv) significant CRP (C-reactive protein) elevation (&gt;10.0 mg/L) and (v) subjects with any GI (gastrointestinal) medications. Since we intended to investigate the association between <italic>H</italic>. <italic>pylori</italic> infection and subclinical atherosclerosis in healthy population, subjects with previous coronary artery disease were excluded. Subjects with thyroid dysfunction and renal insufficiency were omitted as changes in thyroid or renal function influence the level of serum lipids along with coronary atherosclerosis [<xref ref-type="bibr" rid="pone.0193646.ref027">27</xref>–<xref ref-type="bibr" rid="pone.0193646.ref029">29</xref>]. We excluded the subjects with elevated CRP levels as various pro-inflammatory conditions and diseases can affect the progression of atherosclerosis [<xref ref-type="bibr" rid="pone.0193646.ref030">30</xref>,<xref ref-type="bibr" rid="pone.0193646.ref031">31</xref>]. We further excluded the subjects taking GI medications for gastritis or gastric ulcer. Finally, 463 participants were included in the current analysis (<xref ref-type="fig" rid="pone.0193646.g001">Fig 1</xref>). The protocol of this study was approved by the institutional review board of Gangnam Severance Hospital.</p>
<fig id="pone.0193646.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0193646.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Schematic diagram and overall flow of study participants.</title>
<p>Abbreviations: CLO test, rapid urease test; cardiac MDCT, cardiac multidetector computed tomography; PWV, pulse-wave velocity; CVD, cardiovascular disease; TFT, thyroid function test; Cr, creatinine; CRP, C-reactive protein; GI medications, gastrointestinal medications.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0193646.g001" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec004">
<title>Anthropometric and biochemical measurements</title>
<p>We reviewed the participants’ questionnaire at the time of the health check-up, which included medical history, concomitant medication use, and other medico-social history information. After an overnight fasting for ≥8 hours, the fasting plasma glucose, total cholesterol, HDL-cholesterol, triglyceride, calcium, and C-reactive protein levels were checked from the peripheral venous blood samples by means of adequate enzymatic methods (Hitachi 7600–120 automated chemistry analyzer; Hitachi, Tokyo, Japan). The Friedewald formula was used to calculate the low-density lipoprotein-cholesterol (LDL-cholesterol) level.</p>
</sec>
<sec id="sec005">
<title>Coronary artery calcium score, coronary artery stenosis, and coronary plaque measurement with MDCT</title>
<p>Coronary artery calcium scores (CACSs), coronary artery stenosis, and the number, presence and the characteristics of intracoronary plaques were evaluated by using an MDCT scanner (Philips Brilliance 64; Philips Medical System, Best, the Netherlands). A standard prospective electrocardiogram-gating protocol with a step-and-shoot technique (64 × 0.625 mm slice section collimation, 420-ms rotation time, 120-kV tube voltage, and 210-mAs tube current) was used. The CACS was measured (Extended Brilliance Workspace BW V4.5.2.4031, Philips Medical System) and described as Agatston scores. The CACS was interpreted as having either no coronary calcium (CACS 0 vs. &gt;0) or severe coronary calcium (CACS ≤100 vs. &gt;100). Coronary arteries were segmented to 3 major arteries and 12 small branches. Significant coronary artery stenosis was defined as at least ≥50% stenosis in any coronary artery/branch. A plaque was defined as a structure &gt;1 mm<sup>2</sup> within and/or adjacent to the vessel lumen, and classified according to the presence/proportion of intraplaque calcification. The plaques were divided into calcified (calcium [&gt;130 Hounsfield units] content ≥50% of the whole plaque), mixed (calcium content &lt;50% of the whole plaque) or soft (no calcium content). Log{(number of segments with plaque) + 1} was used to analyze the number of segments with plaque.</p>
</sec>
<sec id="sec006">
<title>Pulse-wave velocity</title>
<p>Brachial-ankle PWV (ba-PWV) was assessed by using a volume plethysmographic instrument (VP-1000; Omron Healthcare Corporation, Kyoto, Japan). The ba-PWV was estimated as the value of brachial-ankle distance divided by the blood transit time. An automatic device recorded electrocardiograms, phonocardiograms and the blood pressure (BP) at both the brachial artery and the posterior tibial artery after a stable rest for ≥5 min in supine position. The average value of the right and left sides was defined as the mean PWV.</p>
</sec>
<sec id="sec007">
<title>Rapid urease test</title>
<p>Biopsy of the gastric mucosa was performed to assess the <italic>H</italic>. <italic>pylori</italic> infection status with a commercial CLO kit (ASAN Pharm. Co., Seoul, Korea). Each gastric mucosal biopsy specimen was immediately transferred into the CLO kit and analyzed after 30 min of reaction to determine the test positivity according to the color change of the reaction kit.</p>
</sec>
<sec id="sec008">
<title>Statistical analyses</title>
<p>Continuous variables with normal distribution are presented as mean ± standard error (SE), and those with a skewed distribution, such as CACS or the number of coronary segments with any plaque, were log transformed for analyses. Categorical variables are presented as absolute numbers and percentages. Intergroup comparisons with age adjustment were performed by using analysis of covariance for continuous variables and the generalized estimating equation for categorical variables. Adjusted odds ratios (ORs) for significant coronary artery stenosis in the CLO-positive group compared with the negative group were estimated with logistic regression analysis models. The SPSS statistical package (version 20.0; SPSS Inc., Chicago, IL, USA) was used for all statistical analyses. A <italic>P</italic>-value of ≤0.05 was considered statistically significant.</p>
</sec>
</sec>
<sec id="sec009" sec-type="results">
<title>Results</title>
<sec id="sec010">
<title>Clinical and biochemical characteristics of the study population</title>
<p>A total of 463 subjects (336 men, 127 women, mean age 54.2 ± 8.5 years) were analyzed for the current study and divided into two groups according to the CLO test result. There were 224 (48.4%) CLO-positive and 239 (51.6%) CLO-negative subjects, respectively. The clinical and biochemical characteristics of the study subjects are presented in <xref ref-type="table" rid="pone.0193646.t001">Table 1</xref>. The minimum and maximum age of this whole study population was 31 and 80 years, respectively (33–80 years for the CLO-negative group; and 31–77 years for the CLO-positive group). The mean age was different between the two groups (53.2 ± 7.9 years for the CLO-positive group vs. 55.3 ± 8.9 years for the CLO-negative group, <italic>P</italic> = 0.01). Therefore, comparisons throughout this study were performed after adjustment for age as a confounding variable. The CLO-positive group had a lower mean HDL-cholesterol level (46.6 ± 0.8 mg/dL vs. 49.6 ± 0.8 mg/dL, <italic>P</italic> = 0.01) and a higher mean triglyceride level (134.5 ± 5.7 mg/dL vs. 116.4 ± 5.5 mg/dL, <italic>P</italic> = 0.02). There were no differences in the prevalence of diabetes and hypertension nor the use of antidiabetic, antihypertensive, and antiplatelet agents between the two groups. Subjects in the CLO-positive group were more likely to take a lipid-lowering agent compared to those in the CLO-negative group (15.6% vs. 10.5%, <italic>P</italic> = 0.05).</p>
<table-wrap id="pone.0193646.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0193646.t001</object-id>
<label>Table 1</label> <caption><title>Clinical and biochemical characteristics of study subjects with age adjustment.</title></caption>
<alternatives>
<graphic id="pone.0193646.t001g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0193646.t001" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="justify"/>
<th align="center">Total<break/>N = 463</th>
<th align="center">CLO-negative<break/>N = 239</th>
<th align="center">CLO-positive<break/>N = 224</th>
<th align="center"><italic>P</italic>-value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="justify"><bold>Demographics</bold></td>
<td align="justify"/>
<td align="justify"/>
<td align="justify"/>
<td align="center"/>
</tr>
<tr>
<td align="justify"> Age (yr)</td>
<td align="center">54.2 ± 8.5</td>
<td align="center">55.3 ± 8.9</td>
<td align="center">53.2 ± 7.9</td>
<td align="char" char=".">0.01</td>
</tr>
<tr>
<td align="justify">  minimum and maximum</td>
<td align="center">31–80</td>
<td align="center">33–80</td>
<td align="center">31–77</td>
<td align="center"/>
</tr>
<tr>
<td align="justify"> Male (N, %)</td>
<td align="center">336 (72.6)</td>
<td align="center">165 (69.0)</td>
<td align="center">171 (76.3)</td>
<td align="char" char=".">0.07</td>
</tr>
<tr>
<td align="justify"> Hypertension (N, %)</td>
<td align="center">213 (46.0)</td>
<td align="center">113 (47.3)</td>
<td align="center">100 (44.6)</td>
<td align="char" char=".">0.89</td>
</tr>
<tr>
<td align="justify"> Diabetes (N, %)</td>
<td align="center">79 (17.1)</td>
<td align="center">39 (16.3)</td>
<td align="center">40 (17.9)</td>
<td align="char" char=".">0.35</td>
</tr>
<tr>
<td align="justify"> Diabetes medication (N, %)</td>
<td align="center">46 (9.9)</td>
<td align="center">27 (11.3)</td>
<td align="center">19 (8.5)</td>
<td align="char" char=".">0.58</td>
</tr>
<tr>
<td align="justify"> Lipid lowering agent (N, %)</td>
<td align="center">60 (13.0)</td>
<td align="center">25 (10.5)</td>
<td align="center">35 (15.6)</td>
<td align="char" char=".">0.05</td>
</tr>
<tr>
<td align="justify"> Antiplatelet agent (N, %)</td>
<td align="center">76 (16.4)</td>
<td align="center">42 (17.6)</td>
<td align="center">34 (15.2)</td>
<td align="char" char=".">0.84</td>
</tr>
<tr>
<td align="justify"><bold>Anthropometrics</bold></td>
<td align="justify"/>
<td align="left"/>
<td align="left"/>
<td align="center"/>
</tr>
<tr>
<td align="justify"> Systolic BP (mmHg)</td>
<td align="center">128.2 ± 16.7</td>
<td align="center">128.2 ± 1.1</td>
<td align="center">128.2 ± 1.1</td>
<td align="char" char=".">0.97</td>
</tr>
<tr>
<td align="justify"> Diastolic BP (mmHg)</td>
<td align="center">80.1 ± 9.9</td>
<td align="center">79.8 ± 0.6</td>
<td align="center">80.4 ± 0.7</td>
<td align="char" char=".">0.51</td>
</tr>
<tr>
<td align="justify"> BMI (Kg/m<sup>2</sup>)</td>
<td align="center">24.3 ± 3.1</td>
<td align="center">24.1 ± 0.2</td>
<td align="center">24.5 ± 0.2</td>
<td align="char" char=".">0.26</td>
</tr>
<tr>
<td align="justify"><bold>Laboratory indices</bold></td>
<td align="justify"/>
<td align="left"/>
<td align="left"/>
<td align="center"/>
</tr>
<tr>
<td align="justify"> Fasting glucose (mg/dL)</td>
<td align="center">100.6 ± 24.8</td>
<td align="center">98.9 ± 1.6</td>
<td align="center">102.5 ± 1.7</td>
<td align="char" char=".">0.12</td>
</tr>
<tr>
<td align="justify"> Total cholesterol(mg/dL)</td>
<td align="center">191.3 ± 36.3</td>
<td align="center">193.2 ± 2.3</td>
<td align="center">189.3 ±2.4</td>
<td align="char" char=".">0.25</td>
</tr>
<tr>
<td align="justify"> Triglyceride (mg/dL)</td>
<td align="center">125.2 ± 84.8</td>
<td align="center">116.4 ± 5.5</td>
<td align="center">134.5 ± 5.7</td>
<td align="char" char=".">0.02</td>
</tr>
<tr>
<td align="justify"> HDL-cholesterol (mg/dL)</td>
<td align="center">48.2 ± 12.5</td>
<td align="center">49.6 ± 0.8</td>
<td align="center">46.6 ± 0.8</td>
<td align="char" char=".">0.01</td>
</tr>
<tr>
<td align="justify"> LDL-cholesterol (mg/dL)</td>
<td align="center">116.8 ± 32.9</td>
<td align="center">119.1 ± 2.1</td>
<td align="center">114.3 ± 2.2</td>
<td align="char" char=".">0.12</td>
</tr>
<tr>
<td align="justify"> Calcium (mg/dL)</td>
<td align="center">9.1 ± 0.52</td>
<td align="center">9.1 ± 0.03</td>
<td align="center">9.0 ± 0.03</td>
<td align="char" char=".">0.37</td>
</tr>
<tr>
<td align="justify"> CRP (mg/L)</td>
<td align="center">1.2 ± 1.32</td>
<td align="center">1.2 ± 0.09</td>
<td align="center">1.2 ± 0.09</td>
<td align="char" char=".">0.77</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001"><p>BP, blood pressure; BMI, body mass index; HDL-cholesterol, high density lipoprotein-cholesterol; LDL-cholesterol, low density lipoprotein-cholesterol; CRP, C-reactive protein; DM, diabetes mellitus. A one-way analysis of variance was used to evaluate the difference of continuous variables between CLO positive and negative subjects with age adjustment. The generalized estimating equation was used to compare categorical variables between the CLO positive and negative groups with age adjustment. Continuous variables are presented as mean±standard error or the value of minimum and maximum. Dichotomous variables are presented as the number of subjects with the percentage of subjects in the parenthesis. P &lt; .05 was regarded as statistically significant.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec011">
<title>Differences in PWV, CACS, and incidence of coronary stenosis/intracoronary plaque between the CLO-positive versus the CLO-negative subjects</title>
<p>The presence of coronary artery calcium (CACS &gt;0) was significantly higher in the CLO-positive group (36.7% vs. 32.5%, <italic>P</italic> = 0.05) than in the CLO-negative group. However, there were no statistical differences in the presence of severe coronary artery calcium (CACS &gt;100), the mean value of log(CACS + 1) or the mean PWV between the CLO-positive and CLO-negative subjects. There was also no difference between the two groups not only in the prevalence of any plaque but also in the characteristics of plaque (calcified, mixed, or soft). However, the number of segments with plaque was higher in the CLO-positive group (0.22 ± 0.02 vs. 0.17 ± 0.02, <italic>P</italic> = 0.03). More importantly, the incidence of significant coronary artery stenosis (≥50% stenosis of any major vessel) was significantly higher in the CLO-positive subjects than in the CLO-negative subjects (7.6% vs. 2.9%, <italic>P</italic> = 0.01) (<xref ref-type="table" rid="pone.0193646.t002">Table 2</xref>).</p>
<table-wrap id="pone.0193646.t002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0193646.t002</object-id>
<label>Table 2</label> <caption><title>Difference of subclinical atherosclerosis between the CLO-negative and CLO-positive subjects with age adjustment.</title></caption>
<alternatives>
<graphic id="pone.0193646.t002g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0193646.t002" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left"/>
<th align="center">Total<break/>N = 463</th>
<th align="center">CLO-negative<break/>N = 239</th>
<th align="center">CLO-positive<break/>N = 224</th>
<th align="left"><italic>P</italic>-value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left"><bold>PWV (cm/s)</bold></td>
<td align="center">1422.4 ± 234.3</td>
<td align="center">1419.9 ± 13.1</td>
<td align="center">1425.0 ± 13.5</td>
<td align="char" char=".">0.79</td>
</tr>
<tr>
<td align="left"><bold>CACS</bold></td>
<td align="center" colspan="4"/>
</tr>
<tr>
<td align="left"> CACS &gt;0 (n, %)</td>
<td align="center">157 (34.5)</td>
<td align="center">76 (32.5)</td>
<td align="center">81 (36.7)</td>
<td align="char" char=".">0.05</td>
</tr>
<tr>
<td align="left"> CACS &gt;100 (n, %)</td>
<td align="center">51 (11.2)</td>
<td align="center">27 (11.5)</td>
<td align="center">24 (10.9)</td>
<td align="char" char=".">0.49</td>
</tr>
<tr>
<td align="left"> Log (CACS +1)</td>
<td align="center">0.57 ± 0.87</td>
<td align="center">0.51 ± 0.05</td>
<td align="center">0.64 ± 0.05</td>
<td align="char" char=".">0.08</td>
</tr>
<tr>
<td align="left"><bold>Plaque</bold></td>
<td align="left"/>
<td align="center" colspan="3"/>
</tr>
<tr>
<td align="left"> Any plaque (%)</td>
<td align="center">104 (22.5)</td>
<td align="center">52 (21.8)</td>
<td align="center">52 (23.2)</td>
<td align="char" char=".">0.32</td>
</tr>
<tr>
<td align="left"> Log{(Number of segments with plaque)+1}</td>
<td align="center">0.20 ± 0.26</td>
<td align="center">0.17 ± 0.02</td>
<td align="center">0.22 ± 0.02</td>
<td align="char" char=".">0.03</td>
</tr>
<tr>
<td align="left"> Calcified plaque (%)</td>
<td align="center">58 (12.5)</td>
<td align="center">29 (12.1)</td>
<td align="center">29 (12.9)</td>
<td align="char" char=".">0.38</td>
</tr>
<tr>
<td align="left"> Mixed plaque (%)</td>
<td align="center">41 (8.9)</td>
<td align="center">19 (7.9)</td>
<td align="center">22 (9.8)</td>
<td align="char" char=".">0.25</td>
</tr>
<tr>
<td align="left"> Soft plaque (%)</td>
<td align="center">32 (6.9)</td>
<td align="center">17 (7.1)</td>
<td align="center">15 (6.7)</td>
<td align="char" char=".">0.99</td>
</tr>
<tr>
<td align="left"><bold>Coronary artery stenosis (n, %)</bold></td>
<td align="center">24 (5.2)</td>
<td align="center">7 (2.9)</td>
<td align="center">17 (7.6)</td>
<td align="char" char=".">0.01</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t002fn001"><p>PWV, pulse-wave velocity; CACS, coronary artery calcium score. A one-way analysis of variance was used to evaluate the difference of PWV or number of coronary segments involved between CLO negative and positive subjects with age adjustment. The generalized estimating equation was used to evaluate the difference of dichotomous variables between the two groups with age adjustment. Continuous variables are presented as mean±standard error. Dichotomous variables are presented as the number of subjects with the percentage of subjects in the parenthesis. P &lt; .05 was regarded as statistically significant.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec012">
<title>Elevated adjusted risk for significant coronary artery stenosis in CLO-positive subjects</title>
<p>To investigate whether current <italic>H</italic>. <italic>pylori</italic> infection is an independent risk factor for subclinical atherosclerosis, we evaluated the adjusted risk for significant coronary artery stenosis in the CLO-positive subjects compared with the CLO-negative subjects by analyzing odds ratio (<xref ref-type="table" rid="pone.0193646.t003">Table 3</xref> and <xref ref-type="fig" rid="pone.0193646.g002">Fig 2</xref>). The CLO-positive subjects were 2.72-fold more likely to have significant coronary artery stenosis compared to the CLO-negative subjects. This risk became more significant after adjusting for age and sex (adjusted OR 3.431, 95% confidence interval 1.343–8.765, <italic>P</italic> = 0.01) and also after adjusting for several additional factors that may influence coronary artery stenosis, such as systolic blood pressure (BP), fasting glucose, HDL-cholesterol, anti-hypertension/diabetic medications, lipid-lowering agents, and antiplatelet agents (adjusted OR 2.813, 95% confidence interval 1.051–7.528, <italic>P</italic> = 0.04).</p>
<fig id="pone.0193646.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0193646.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Odds ratio for significant coronary artery stenosis according to the CLO test.</title>
<p>Logistic regression was used for calculating odds ratios with 95% confidence intervals. The reference group comprised the CLO-negative subjects.</p>
<p><list list-type="simple">
<list-item><p>Model 1: Not adjusted</p></list-item>
<list-item><p>Model 2: adjusted for age and sex</p></list-item>
<list-item><p>Model 3: adjusted for age, sex, HDL-cholesterol</p></list-item>
<list-item><p>Model 4: adjusted for age, sex, systolic BP, fasting glucose, HDL-cholesterol, anti-hypertension medication, anti-diabetic medication, lipid lowering agent, anti-platelet agent</p></list-item>
</list></p>
<p>Abbreviations: OR, odds ratio; CI, confidence interval; BP, blood pressure; HDL-cholesterol, high density lipoprotein-cholesterol.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0193646.g002" xlink:type="simple"/>
</fig>
<table-wrap id="pone.0193646.t003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0193646.t003</object-id>
<label>Table 3</label> <caption><title>Odds ratio for significant coronary artery stenosis.</title></caption>
<alternatives>
<graphic id="pone.0193646.t003g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0193646.t003" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left" rowspan="2"/>
<th align="center" colspan="2">Odds ratio (95% CI)</th>
<th align="center" rowspan="2"><italic>P</italic>-value</th>
</tr>
<tr>
<th align="center">CLO-negative<break/>N = 239</th>
<th align="center">CLO-positive<break/>N = 224</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">Model 1</td>
<td align="center" rowspan="4">1.000 (reference)</td>
<td align="center">2.722 (1.107–6.694)</td>
<td align="char" char=".">0.03</td>
</tr>
<tr>
<td align="left">Model 2</td>
<td align="center">3.431 (1.343–8.765)</td>
<td align="char" char=".">0.01</td>
</tr>
<tr>
<td align="left">Model 3</td>
<td align="center">3.330 (1.285–8.629)</td>
<td align="char" char=".">0.01</td>
</tr>
<tr>
<td align="left">Model 4</td>
<td align="center">2.813 (1.051–7.528)</td>
<td align="char" char=".">0.04</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t003fn001">
<p><list list-type="simple">
<list-item><p>Model 1: Not adjusted</p></list-item>
<list-item><p>Model 2: adjusted for age and sex</p></list-item>
<list-item><p>Model 3: adjusted for age, sex, HDL-cholesterol</p></list-item>
<list-item><p>Model 4: adjusted for age, sex, systolic BP, fasting glucose, HDL-cholesterol, anti-hypertension medication, anti-diabetic medication, lipid lowering agent, anti-platelet agent</p></list-item>
</list></p></fn>
<fn id="t003fn002"><p>CI, confidence interval; BP, blood pressure; HDL-cholesterol, high density lipoprotein-cholesterol. Data are presented as odds ratios with the CLO-negative group as a reference.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec id="sec013" sec-type="conclusions">
<title>Discussion</title>
<p>In this study, we demonstrated that current <italic>H</italic>. <italic>pylori</italic> infection is significantly associated with significant coronary artery stenosis in a healthy population. The elevated risk of coronary artery stenosis in <italic>H</italic>. <italic>pylori</italic>-infected subjects was associated with a lower HDL-cholesterol level. This is the first report demonstrating that active/current <italic>H</italic>. <italic>pylori</italic> infection can be a risk for subclinical atherosclerosis in healthy subjects without previous CVD.</p>
<p>The diagnostic tests for <italic>H</italic>. <italic>pylori</italic> can be divided into invasive and noninvasive methods. The serologic <italic>H</italic>. <italic>pylori</italic> IgG test, urea breath test, and stool antigen assay are noninvasive, whereas the CLO test can only be performed with stomach tissue obtained from invasive endoscopic biopsy [<xref ref-type="bibr" rid="pone.0193646.ref025">25</xref>]. As the serologic <italic>H</italic>. <italic>pylori</italic> IgG test is fast, cheap, and noninvasive, most of the studies on <italic>H</italic>. <italic>pylori</italic> infection and CVD were performed using this test [<xref ref-type="bibr" rid="pone.0193646.ref017">17</xref>,<xref ref-type="bibr" rid="pone.0193646.ref018">18</xref>,<xref ref-type="bibr" rid="pone.0193646.ref020">20</xref>,<xref ref-type="bibr" rid="pone.0193646.ref032">32</xref>–<xref ref-type="bibr" rid="pone.0193646.ref035">35</xref>]. However, conflicting results exist between the serology and the prevalence of CVD, with some studies showing a significant association between <italic>H</italic>. <italic>pylori</italic> seropositivity and CVD [<xref ref-type="bibr" rid="pone.0193646.ref012">12</xref>,<xref ref-type="bibr" rid="pone.0193646.ref017">17</xref>,<xref ref-type="bibr" rid="pone.0193646.ref018">18</xref>,<xref ref-type="bibr" rid="pone.0193646.ref020">20</xref>,<xref ref-type="bibr" rid="pone.0193646.ref032">32</xref>] while others showing no such association [<xref ref-type="bibr" rid="pone.0193646.ref033">33</xref>–<xref ref-type="bibr" rid="pone.0193646.ref035">35</xref>]. One of the possible reasons for these conflicting results may be certain limitations of the serologic test in detecting <italic>H</italic>. <italic>pylori</italic> infection itself [<xref ref-type="bibr" rid="pone.0193646.ref036">36</xref>]. Most importantly, serologic antibody testing cannot distinguish current and past infection.[<xref ref-type="bibr" rid="pone.0193646.ref026">26</xref>] Owing to this limitation, the serologic test has been mostly used to investigate merely the association between the prevalence of <italic>H</italic>. <italic>pylori</italic> infection and CVD [<xref ref-type="bibr" rid="pone.0193646.ref018">18</xref>,<xref ref-type="bibr" rid="pone.0193646.ref032">32</xref>,<xref ref-type="bibr" rid="pone.0193646.ref037">37</xref>]. In contrast, a positive CLO test means a current infection [<xref ref-type="bibr" rid="pone.0193646.ref026">26</xref>]. If current <italic>H</italic>. <italic>pylori</italic> infection is associated with subclinical atherosclerosis, it can be inferred that the eradication of <italic>H</italic>. <italic>pylori</italic> infection might help prevent the progression of atherosclerosis. In this context, this study provides a theoretical basis for studying the effect of <italic>H</italic>. <italic>pylori</italic> eradication on preventing the future progression of atherosclerosis.</p>
<p>However, the CLO test is not without limitations. For example, although atrophic gastritis is explicitly associated with <italic>H</italic>. <italic>pylori</italic> in many cases, the CLO test may fail to detect the presence of <italic>H</italic>. <italic>pylori</italic> because of a decreased bacterial burden in atrophic gastritis, particularly in the presence of intestinal metaplasia [<xref ref-type="bibr" rid="pone.0193646.ref026">26</xref>]. Nevertheless, the CLO test can provide more accurate and reliable results than the serologic test [<xref ref-type="bibr" rid="pone.0193646.ref025">25</xref>]. The specificity of the CLO test is 95–100%, whereas the serologic test has variable specificity ranging from 76% to 96% [<xref ref-type="bibr" rid="pone.0193646.ref025">25</xref>]. Moreover, the CLO test has a higher sensitivity (80–95%) than the serologic test (75–85%) [<xref ref-type="bibr" rid="pone.0193646.ref026">26</xref>]. Hence, our data provide more accurate evidence for examining the association between <italic>H</italic>. <italic>pylori</italic> infection and CVD compared with previous studies with the serologic test.</p>
<p>Several studies have reported the correlation between the prevalence of <italic>H</italic>. <italic>pylori</italic> infection and overt coronary artery disease [<xref ref-type="bibr" rid="pone.0193646.ref011">11</xref>,<xref ref-type="bibr" rid="pone.0193646.ref017">17</xref>–<xref ref-type="bibr" rid="pone.0193646.ref021">21</xref>]. However, no study has demonstrated the association between current <italic>H</italic>. <italic>pylori</italic> infection and subclinical coronary atherosclerosis. This study is distinct from previous studies because we did not observe CVD events but the incidence of subclinical coronary atherosclerosis in a relatively large number of healthy subjects without previous CVD. Atherosclerosis is a pathologic process narrowing the coronary, cerebral, and peripheral arteries due to the formation of atheromatous plaques [<xref ref-type="bibr" rid="pone.0193646.ref038">38</xref>]. Studying the association between <italic>H</italic>. <italic>pylori</italic> infection and subclinical atherosclerosis allows investigators to confirm that earlier vessel-wall changes can be induced by <italic>H</italic>. <italic>pylori</italic> infection. Some reports have shown the association between <italic>H</italic>. <italic>pylori</italic> infection and the degree of carotid atherosclerosis, but not with that of coronary atherosclerosis [<xref ref-type="bibr" rid="pone.0193646.ref039">39</xref>–<xref ref-type="bibr" rid="pone.0193646.ref041">41</xref>]. To our knowledge, this is the first study that employed the CLO test to detect current <italic>H</italic>. <italic>pylori</italic> infection, and linked this test with direct visualization of the coronary artery with cardiac MDCT in a relatively large number of healthy subjects. The significant correlation between <italic>H</italic>. <italic>pylori</italic> infection and subclinical coronary atherosclerosis in this study might be able to support <italic>H</italic>. <italic>pylori</italic> eradication as a potential cardiovascular prevention strategy.</p>
<p>How <italic>H</italic>. <italic>pylori</italic> infection can induce atherosclerosis has not been clearly established yet [<xref ref-type="bibr" rid="pone.0193646.ref010">10</xref>,<xref ref-type="bibr" rid="pone.0193646.ref029">29</xref>]. In this study, HDL-cholesterol was lower and triglyceride was higher in the CLO-positive group. Some data suggest that dysregulated lipid metabolism, including a low HDL-cholesterol level, may accelerate atherosclerosis in patients with <italic>H</italic>. <italic>pylori</italic> infection [<xref ref-type="bibr" rid="pone.0193646.ref010">10</xref>,<xref ref-type="bibr" rid="pone.0193646.ref042">42</xref>–<xref ref-type="bibr" rid="pone.0193646.ref045">45</xref>]. <italic>Helicobacter pylori</italic> carries lipopolysaccharide and can upregulate certain cytokines in the host, such as tumor necrosis factor-α (TNF-α) [<xref ref-type="bibr" rid="pone.0193646.ref009">9</xref>,<xref ref-type="bibr" rid="pone.0193646.ref010">10</xref>,<xref ref-type="bibr" rid="pone.0193646.ref035">35</xref>]. Inhibition of lipoprotein lipase by cytokines, such as TNF-α, may mobilize lipids from the tissues [<xref ref-type="bibr" rid="pone.0193646.ref046">46</xref>], leading to low serum HDL-cholesterol levels [<xref ref-type="bibr" rid="pone.0193646.ref047">47</xref>]. Besides perturbing the lipid metabolism, <italic>H</italic>. <italic>pylori</italic> infection may also directly induce atherosclerosis. Endothelial dysfunction induced by vacuolating cytotoxin A secreted from <italic>H</italic>. <italic>pylori</italic> [<xref ref-type="bibr" rid="pone.0193646.ref048">48</xref>,<xref ref-type="bibr" rid="pone.0193646.ref049">49</xref>], molecular mimicry by the autoimmune response [<xref ref-type="bibr" rid="pone.0193646.ref050">50</xref>], enhanced systemic inflammation [<xref ref-type="bibr" rid="pone.0193646.ref051">51</xref>], oxidative stress [<xref ref-type="bibr" rid="pone.0193646.ref052">52</xref>], and platelet aggregation [<xref ref-type="bibr" rid="pone.0193646.ref053">53</xref>] by <italic>H</italic>. <italic>pylori</italic> are all potential mechanisms of atherosclerosis that have been reported to be directly induced by <italic>H</italic>. <italic>pylori</italic> infection. The possibility of <italic>H</italic>. <italic>pylori</italic> induced-atherosclerosis independent of HDL-cholesterol levels is also supported by our data showing that <italic>H</italic>. <italic>pylori</italic> itself is associated with a higher incidence of significant coronary artery stenosis despite adjusting for HDL-cholesterol level. This significant association between <italic>H</italic>. <italic>pylori</italic> and significant coronary artery stenosis, irrespective of disturbed HDL-cholesterol levels, suggests that <italic>H</italic>. <italic>pylori</italic> infection may aggravate coronary atherosclerosis through both lipid metabolism-dependent and independent pathways.</p>
<p>CACS has also been used for suggesting the association between <italic>H</italic>. <italic>pylori</italic> seropositivity and coronary atherosclerosis. In a previous study, the degree of coronary atherosclerosis assessed by CACS was significantly associated with <italic>H</italic>. <italic>pylori</italic> seropositivity [<xref ref-type="bibr" rid="pone.0193646.ref032">32</xref>]. In our study, the presence of coronary artery calcium (CACS &gt;0) was significantly higher in the CLO-positive group. On the other hand, there were no statistical differences in the presence of severe coronary artery calcium (CACS &gt;100) and the mean value of log(CACS + 1) between the CLO-positive and CLO-negative subjects. Considering that CACS is more specific in subjects older than 60 years [<xref ref-type="bibr" rid="pone.0193646.ref054">54</xref>,<xref ref-type="bibr" rid="pone.0193646.ref055">55</xref>], the relationship between CACS and <italic>H</italic>. <italic>pylori</italic> infection needs to be further investigated in a larger study population.</p>
<p>The link between <italic>H</italic>. <italic>pylori</italic> infection and increased arterial PWV has been documented previously [<xref ref-type="bibr" rid="pone.0193646.ref056">56</xref>,<xref ref-type="bibr" rid="pone.0193646.ref057">57</xref>]. As chronic <italic>H</italic>. <italic>pylori</italic> infection is thought to induce systemic inflammation through cytokines such as interleukin-6 [<xref ref-type="bibr" rid="pone.0193646.ref044">44</xref>,<xref ref-type="bibr" rid="pone.0193646.ref051">51</xref>], not only coronary but also peripheral vascular changes can occur [<xref ref-type="bibr" rid="pone.0193646.ref058">58</xref>]. However, the mean PWV was not different according to the CLO positivity in our study. These inconsistent results may possibly be because of the differences in the PWV measurement sites (heart-carotid vs. brachial-ankle) and differences in the study population, as well as the diagnostic tool for <italic>H</italic>. <italic>pylori</italic> infection [<xref ref-type="bibr" rid="pone.0193646.ref056">56</xref>,<xref ref-type="bibr" rid="pone.0193646.ref057">57</xref>]. In addition, considering the previous reports that bacterial DNA of <italic>H</italic>. <italic>pylori</italic> was identified in coronary atherosclerotic plaque [<xref ref-type="bibr" rid="pone.0193646.ref010">10</xref>,<xref ref-type="bibr" rid="pone.0193646.ref059">59</xref>,<xref ref-type="bibr" rid="pone.0193646.ref060">60</xref>], <italic>H</italic>. <italic>pylori</italic> might be able to aggravate coronary atherosclerosis by direct invasion into the coronary vessels preferentially compared to other vessels regardless of systemic inflammation.</p>
<p>Our study has several limitations. First, this study lacks the measurement of cytotoxin-associated gene-A (CagA), which has been known to determine the pathogenicity of <italic>H</italic>. <italic>pylori</italic> in atherosclerosis [<xref ref-type="bibr" rid="pone.0193646.ref061">61</xref>–<xref ref-type="bibr" rid="pone.0193646.ref063">63</xref>]. It would be necessary to investigate this in future studies. Other limitations of this study are characteristics of the study population. As Gangnam Severance hospital is located in an affluent part of the capital city, the demographic and the socio-economic characteristics might be different from the general population. The individuals in our study population were more likely to be male, aged and upper white-collar workers prominently [<xref ref-type="bibr" rid="pone.0193646.ref064">64</xref>,<xref ref-type="bibr" rid="pone.0193646.ref065">65</xref>]. Lastly, we could not discriminate the subjects who had <italic>H</italic>. <italic>pylori</italic> eradication treatment previously because this was not included in the questionnaire of the health check-up. Nevertheless, our study is powerful and unique in demonstrating the association between subclinical atherosclerosis and <italic>H</italic>. <italic>pylori</italic> infection compared to other studies because our dataset is composed of extensive data encompassing MDCT, PWV, and CLO-test, the results of which are difficult to gather comprehensively.</p>
<p>In conclusion, current <italic>H</italic>. <italic>pylori</italic> infection is associated with subclinical but significant coronary artery stenosis in a healthy population. This result suggests the possibility that <italic>H</italic>. <italic>pylori</italic> eradication might be worthwhile in preventing coronary artery disease. Further studies are warranted to investigate whether CLO test positivity could be a new marker for the assessment of future coronary artery disease risk and the underlying mechanism of how <italic>H</italic>. <italic>pylori</italic> infection may lead to coronary atherosclerosis.</p>
</sec>
</body>
<back>
<ack>
<p>We would like to thank the Gangnam Severance Hospital Health Promotion Center for sharing the check-up data for analyses. We are also grateful to Dr. Lee and Ms. Hong (the Biostatistics Collaboration Units of Yonsei University College of Medicine) for their advice on the statistical analyses.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pone.0193646.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Epstein</surname> <given-names>SE</given-names></name>, <name name-style="western"><surname>Zhou</surname> <given-names>YF</given-names></name>, <name name-style="western"><surname>Zhu</surname> <given-names>J</given-names></name>. <article-title>Infection and atherosclerosis: emerging mechanistic paradigms</article-title>. <source>Circulation</source>. <year>1999</year>;<volume>100</volume>: <fpage>e20</fpage>–<lpage>28</lpage>. <object-id pub-id-type="pmid">10421626</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ayada</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Yokota</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Kobayashi</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Shoenfeld</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Matsuura</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Oguma</surname> <given-names>K</given-names></name>. <article-title>Chronic infections and atherosclerosis</article-title>. <source>Ann N Y Acad Sci</source>. <year>2007</year>;<volume>1108</volume>: <fpage>594</fpage>–<lpage>602</lpage>. <object-id pub-id-type="pmid">17894024</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Coskun</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Kasirga</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Yilmaz</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>Bayindir</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Akil</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Yuksel</surname> <given-names>H</given-names></name>, <etal>et al</etal>. <article-title>Is Helicobacter pylori related to endothelial dysfunction during childhood?</article-title> <source>Pediatr Int</source>. <year>2008</year>;<volume>50</volume>: <fpage>150</fpage>–<lpage>153</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1442-200X.2008.02542.x" xlink:type="simple">10.1111/j.1442-200X.2008.02542.x</ext-link></comment> <object-id pub-id-type="pmid">18353048</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Meng</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Qiao</surname> <given-names>L</given-names></name>. <article-title>Helicobacter pylori-induced gastric inflammation and gastric cancer</article-title>. <source>Cancer Lett</source>. <year>2014</year>;<volume>345</volume>: <fpage>196</fpage>–<lpage>202</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.canlet.2013.08.016" xlink:type="simple">10.1016/j.canlet.2013.08.016</ext-link></comment> <object-id pub-id-type="pmid">23981572</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yamaoka</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Graham</surname> <given-names>DY</given-names></name>. <article-title>Helicobacter pylori virulence and cancer pathogenesis</article-title>. <source>Future Oncol</source>. <year>2014</year>;<volume>10</volume>: <fpage>1487</fpage>–<lpage>1500</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2217/fon.14.29" xlink:type="simple">10.2217/fon.14.29</ext-link></comment> <object-id pub-id-type="pmid">25052757</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mentis</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Lehours</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Megraud</surname> <given-names>F</given-names></name>. <article-title>Epidemiology and Diagnosis of Helicobacter pylori infection</article-title>. <source>Helicobacter</source>. <year>2015</year>;<volume>20</volume> <issue>Suppl 1</issue>: <fpage>1</fpage>–<lpage>7</lpage>.</mixed-citation></ref>
<ref id="pone.0193646.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Blankenberg</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Rupprecht</surname> <given-names>HJ</given-names></name>, <name name-style="western"><surname>Bickel</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Hafner</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Meyer</surname> <given-names>J</given-names></name>. [<article-title>The role of inflammation and infection in acute coronary syndrome</article-title>]. <source>Herz</source>. <year>2001</year>;<volume>26</volume> <issue>Suppl 1</issue>: <fpage>9</fpage>–<lpage>18</lpage>.</mixed-citation></ref>
<ref id="pone.0193646.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rezaee-Zavareh</surname> <given-names>MS</given-names></name>, <name name-style="western"><surname>Tohidi</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Sabouri</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Ramezani-Binabaj</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Sadeghi-Ghahrodi</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Einollahi</surname> <given-names>B</given-names></name>. <article-title>Infectious and coronary artery disease</article-title>. <source>ARYA Atheroscler</source>. <year>2016</year>;<volume>12</volume>: <fpage>41</fpage>–<lpage>49</lpage>. <object-id pub-id-type="pmid">27114736</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kountouras</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Polyzos</surname> <given-names>SA</given-names></name>, <name name-style="western"><surname>Katsinelos</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Zeglinas</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Artemaki</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Tzivras</surname> <given-names>D</given-names></name>, <etal>et al</etal>. <article-title>Cardio-cerebrovascular disease and Helicobacter pylori-related metabolic syndrome: We consider eradication therapy as a potential cardio-cerebrovascular prevention strategy</article-title>. <source>Int J Cardiol</source>. <year>2017</year>;<volume>229</volume>: <fpage>17</fpage>–<lpage>18</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ijcard.2016.11.265" xlink:type="simple">10.1016/j.ijcard.2016.11.265</ext-link></comment> <object-id pub-id-type="pmid">27887801</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Manolakis</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Kapsoritakis</surname> <given-names>AN</given-names></name>, <name name-style="western"><surname>Potamianos</surname> <given-names>SP</given-names></name>. <article-title>A review of the postulated mechanisms concerning the association of Helicobacter pylori with ischemic heart disease</article-title>. <source>Helicobacter</source>. <year>2007</year>;<volume>12</volume>: <fpage>287</fpage>–<lpage>297</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1523-5378.2007.00511.x" xlink:type="simple">10.1111/j.1523-5378.2007.00511.x</ext-link></comment> <object-id pub-id-type="pmid">17669100</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sun</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Rangan</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Bhat</surname> <given-names>SS</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>L</given-names></name>. <article-title>A Meta-Analysis of the Association between Helicobacter pylori Infection and Risk of Coronary Heart Disease from Published Prospective Studies</article-title>. <source>Helicobacter</source>. <year>2016</year>;<volume>21</volume>: <fpage>11</fpage>–<lpage>23</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/hel.12234" xlink:type="simple">10.1111/hel.12234</ext-link></comment> <object-id pub-id-type="pmid">25997465</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tabata</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Sueta</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Akasaka</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Arima</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Sakamoto</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Yamamoto</surname> <given-names>E</given-names></name>, <etal>et al</etal>. <article-title>Helicobacter pylori Seropositivity in Patients with Interleukin-1 Polymorphisms Is Significantly Associated with ST-Segment Elevation Myocardial Infarction</article-title>. <source>PLoS One</source>. <year>2016</year>;<volume>11</volume>: <fpage>e0166240</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0166240" xlink:type="simple">10.1371/journal.pone.0166240</ext-link></comment> <object-id pub-id-type="pmid">27832202</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Al-Nozha</surname> <given-names>MM</given-names></name>, <name name-style="western"><surname>Khalil</surname> <given-names>MZ</given-names></name>, <name name-style="western"><surname>Al-Mofleh</surname> <given-names>IA</given-names></name>, <name name-style="western"><surname>Al-Ghamdi</surname> <given-names>AS</given-names></name>. <article-title>Lack of association of coronary artery disease with H.pylori infection</article-title>. <source>Saudi Med J</source>. <year>2003</year>;<volume>24</volume>: <fpage>1370</fpage>–<lpage>1373</lpage>. <object-id pub-id-type="pmid">14710286</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kanbay</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Gur</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Yucel</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Yilmaz</surname> <given-names>U</given-names></name>, <name name-style="western"><surname>Muderrisoglu</surname> <given-names>H</given-names></name>. <article-title>Helicobacter pylori seroprevalence in patients with coronary artery disease</article-title>. <source>Dig Dis Sci</source>. <year>2005</year>;<volume>50</volume>: <fpage>2071</fpage>–<lpage>2074</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s10620-005-3009-7" xlink:type="simple">10.1007/s10620-005-3009-7</ext-link></comment> <object-id pub-id-type="pmid">16240217</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Quinn</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Foley</surname> <given-names>JB</given-names></name>, <name name-style="western"><surname>Mulvihill</surname> <given-names>NT</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Crean</surname> <given-names>PA</given-names></name>, <name name-style="western"><surname>Walsh</surname> <given-names>MJ</given-names></name>, <etal>et al</etal>. <article-title>Helicobacter pylori serology in patients with angiographically documented coronary artery disease</article-title>. <source>Am J Cardiol</source>. <year>1999</year>;<volume>83</volume>: <fpage>1664</fpage>–<lpage>1666</lpage>, <fpage>A1666</fpage>. <object-id pub-id-type="pmid">10392873</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tsai</surname> <given-names>CJ</given-names></name>, <name name-style="western"><surname>Huang</surname> <given-names>TY</given-names></name>. <article-title>Relation of Helicobacter pylori infection and angiographically demonstrated coronary artery disease</article-title>. <source>Dig Dis Sci</source>. <year>2000</year>;<volume>45</volume>: <fpage>1227</fpage>–<lpage>1232</lpage>. <object-id pub-id-type="pmid">10877241</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chmiela</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Kowalewicz-Kulbat</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Miszczak</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Wisniewska</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Rechcinski</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Kolodziej</surname> <given-names>K</given-names></name>, <etal>et al</etal>. <article-title>A link between Helicobacter pylori and/or Chlamydia spp. infections and atherosclerosis</article-title>. <source>FEMS Immunol Med Microbiol</source>. <year>2003</year>;<volume>36</volume>: <fpage>187</fpage>–<lpage>192</lpage>. <object-id pub-id-type="pmid">12738390</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kowalski</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Konturek</surname> <given-names>PC</given-names></name>, <name name-style="western"><surname>Pieniazek</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Karczewska</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Kluczka</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Grove</surname> <given-names>R</given-names></name>, <etal>et al</etal>. <article-title>Prevalence of Helicobacter pylori infection in coronary artery disease and effect of its eradication on coronary lumen reduction after percutaneous coronary angioplasty</article-title>. <source>Dig Liver Dis</source>. <year>2001</year>;<volume>33</volume>: <fpage>222</fpage>–<lpage>229</lpage>. <object-id pub-id-type="pmid">11407666</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jin</surname> <given-names>SW</given-names></name>, <name name-style="western"><surname>Her</surname> <given-names>SH</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Yoon</surname> <given-names>HJ</given-names></name>, <name name-style="western"><surname>Moon</surname> <given-names>SJ</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>PJ</given-names></name>, <etal>et al</etal>. <article-title>The association between current Helicobacter pylori infection and coronary artery disease</article-title>. <source>Korean J Intern Med</source>. <year>2007</year>;<volume>22</volume>: <fpage>152</fpage>–<lpage>156</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3904/kjim.2007.22.3.152" xlink:type="simple">10.3904/kjim.2007.22.3.152</ext-link></comment> <object-id pub-id-type="pmid">17939331</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Schottker</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Adamu</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Weck</surname> <given-names>MN</given-names></name>, <name name-style="western"><surname>Muller</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Brenner</surname> <given-names>H</given-names></name>. <article-title>Helicobacter pylori infection, chronic atrophic gastritis and major cardiovascular events: a population-based cohort study</article-title>. <source>Atherosclerosis</source>. <year>2012</year>;<volume>220</volume>: <fpage>569</fpage>–<lpage>574</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.atherosclerosis.2011.11.029" xlink:type="simple">10.1016/j.atherosclerosis.2011.11.029</ext-link></comment> <object-id pub-id-type="pmid">22189198</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yu</surname> <given-names>XJ</given-names></name>, <name name-style="western"><surname>Yang</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Feng</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>LL</given-names></name>, <name name-style="western"><surname>Dong</surname> <given-names>QJ</given-names></name>. <article-title>Association between Helicobacter pylori infection and angiographically demonstrated coronary artery disease: A meta-analysis</article-title>. <source>Exp Ther Med</source>. <year>2017</year>;<volume>13</volume>: <fpage>787</fpage>–<lpage>793</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3892/etm.2017.4028" xlink:type="simple">10.3892/etm.2017.4028</ext-link></comment> <object-id pub-id-type="pmid">28352367</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kuller</surname> <given-names>LH</given-names></name>, <name name-style="western"><surname>Arnold</surname> <given-names>AM</given-names></name>, <name name-style="western"><surname>Psaty</surname> <given-names>BM</given-names></name>, <name name-style="western"><surname>Robbins</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>O’Leary</surname> <given-names>DH</given-names></name>, <name name-style="western"><surname>Tracy</surname> <given-names>RP</given-names></name>, <etal>et al</etal>. <article-title>10-year follow-up of subclinical cardiovascular disease and risk of coronary heart disease in the Cardiovascular Health Study</article-title>. <source>Arch Intern Med</source>. <year>2006</year>;<volume>166</volume>: <fpage>71</fpage>–<lpage>78</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1001/archinte.166.1.71" xlink:type="simple">10.1001/archinte.166.1.71</ext-link></comment> <object-id pub-id-type="pmid">16401813</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kuller</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Borhani</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Furberg</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Gardin</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Manolio</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>O’Leary</surname> <given-names>D</given-names></name>, <etal>et al</etal>. <article-title>Prevalence of subclinical atherosclerosis and cardiovascular disease and association with risk factors in the Cardiovascular Health Study</article-title>. <source>Am J Epidemiol</source>. <year>1994</year>;<volume>139</volume>: <fpage>1164</fpage>–<lpage>1179</lpage>. <object-id pub-id-type="pmid">8209875</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Silverman</surname> <given-names>MG</given-names></name>, <name name-style="western"><surname>Harkness</surname> <given-names>JR</given-names></name>, <name name-style="western"><surname>Blankstein</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Budoff</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Agatston</surname> <given-names>AS</given-names></name>, <name name-style="western"><surname>Carr</surname> <given-names>JJ</given-names></name>, <etal>et al</etal>. <article-title>Baseline subclinical atherosclerosis burden and distribution are associated with frequency and mode of future coronary revascularization: multi-ethnic study of atherosclerosis</article-title>. <source>JACC Cardiovasc Imaging</source>. <year>2014</year>;<volume>7</volume>: <fpage>476</fpage>–<lpage>486</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jcmg.2014.03.005" xlink:type="simple">10.1016/j.jcmg.2014.03.005</ext-link></comment> <object-id pub-id-type="pmid">24831208</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chey</surname> <given-names>WD</given-names></name>, <name name-style="western"><surname>Wong</surname> <given-names>BC</given-names></name>, <collab>Practice Parameters Committee of the American College of G</collab>. <article-title>American College of Gastroenterology guideline on the management of Helicobacter pylori infection</article-title>. <source>Am J Gastroenterol</source>. <year>2007</year>;<volume>102</volume>: <fpage>1808</fpage>–<lpage>1825</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1572-0241.2007.01393.x" xlink:type="simple">10.1111/j.1572-0241.2007.01393.x</ext-link></comment> <object-id pub-id-type="pmid">17608775</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Atkinson</surname> <given-names>NS</given-names></name>, <name name-style="western"><surname>Braden</surname> <given-names>B</given-names></name>. <article-title>Helicobacter Pylori Infection: Diagnostic Strategies in Primary Diagnosis and After Therapy</article-title>. <source>Dig Dis Sci</source>. <year>2016</year>;<volume>61</volume>: <fpage>19</fpage>–<lpage>24</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s10620-015-3877-4" xlink:type="simple">10.1007/s10620-015-3877-4</ext-link></comment> <object-id pub-id-type="pmid">26391269</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Duntas</surname> <given-names>LH</given-names></name>, <name name-style="western"><surname>Wartofsky</surname> <given-names>L</given-names></name>. <article-title>Cardiovascular risk and subclinical hypothyroidism: focus on lipids and new emerging risk factors. What is the evidence?</article-title> <source>Thyroid</source>. <year>2007</year>;<volume>17</volume>: <fpage>1075</fpage>–<lpage>1084</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1089/thy.2007.0116" xlink:type="simple">10.1089/thy.2007.0116</ext-link></comment> <object-id pub-id-type="pmid">17900236</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chon</surname> <given-names>SJ</given-names></name>, <name name-style="western"><surname>Heo</surname> <given-names>JY</given-names></name>, <name name-style="western"><surname>Yun</surname> <given-names>BH</given-names></name>, <name name-style="western"><surname>Jung</surname> <given-names>YS</given-names></name>, <name name-style="western"><surname>Seo</surname> <given-names>SK</given-names></name>. <article-title>Serum Thyroid Stimulating Hormone Levels Are Associated with the Presence of Coronary Atherosclerosis in Healthy Postmenopausal Women</article-title>. <source>J Menopausal Med</source>. <year>2016</year>;<volume>22</volume>: <fpage>146</fpage>–<lpage>153</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.6118/jmm.2016.22.3.146" xlink:type="simple">10.6118/jmm.2016.22.3.146</ext-link></comment> <object-id pub-id-type="pmid">28119894</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liu</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>XC</given-names></name>, <name name-style="western"><surname>Lu</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Cao</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Sun</surname> <given-names>RR</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Cardiovascular disease and its relationship with chronic kidney disease</article-title>. <source>Eur Rev Med Pharmacol Sci</source>. <year>2014</year>;<volume>18</volume>: <fpage>2918</fpage>–<lpage>2926</lpage>. <object-id pub-id-type="pmid">25339487</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mason</surname> <given-names>JC</given-names></name>, <name name-style="western"><surname>Libby</surname> <given-names>P</given-names></name>. <article-title>Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions</article-title>. <source>Eur Heart J</source>. <year>2015</year>;<volume>36</volume>: <fpage>482</fpage>–<lpage>489c</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/eurheartj/ehu403" xlink:type="simple">10.1093/eurheartj/ehu403</ext-link></comment> <object-id pub-id-type="pmid">25433021</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>de Ferranti</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Rifai</surname> <given-names>N</given-names></name>. <article-title>C-reactive protein and cardiovascular disease: a review of risk prediction and interventions</article-title>. <source>Clin Chim Acta</source>. <year>2002</year>;<volume>317</volume>: <fpage>1</fpage>–<lpage>15</lpage>. <object-id pub-id-type="pmid">11814453</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Park</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Choi</surname> <given-names>SH</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Kang</surname> <given-names>SJ</given-names></name>, <name name-style="western"><surname>Chung</surname> <given-names>SJ</given-names></name>, <name name-style="western"><surname>Choi</surname> <given-names>SY</given-names></name>, <etal>et al</etal>. <article-title>Association between Helicobacter pylori Seropositivity and the Coronary Artery Calcium Score in a Screening Population</article-title>. <source>Gut Liver</source>. <year>2011</year>;<volume>5</volume>: <fpage>321</fpage>–<lpage>327</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5009/gnl.2011.5.3.321" xlink:type="simple">10.5009/gnl.2011.5.3.321</ext-link></comment> <object-id pub-id-type="pmid">21927661</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ikeda</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Iso</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Sasazuki</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Inoue</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Tsugane</surname> <given-names>S</given-names></name>, <collab>Group JS</collab>. <article-title>The combination of Helicobacter pylori- and cytotoxin-associated gene-A seropositivity in relation to the risk of myocardial infarction in middle-aged Japanese: The Japan Public Health Center-based study</article-title>. <source>Atherosclerosis</source>. <year>2013</year>;<volume>230</volume>: <fpage>67</fpage>–<lpage>72</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.atherosclerosis.2013.06.013" xlink:type="simple">10.1016/j.atherosclerosis.2013.06.013</ext-link></comment> <object-id pub-id-type="pmid">23958254</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rogha</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Nikvarz</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Pourmoghaddas</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Shirneshan</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Dadkhah</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Pourmoghaddas</surname> <given-names>M</given-names></name>. <article-title>Is helicobacter pylori infection a risk factor for coronary heart disease?</article-title> <source>ARYA Atheroscler</source>. <year>2012</year>;<volume>8</volume>: <fpage>5</fpage>–<lpage>8</lpage>. <object-id pub-id-type="pmid">23056092</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Adiloglu</surname> <given-names>AK</given-names></name>, <name name-style="western"><surname>Can</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Kinay</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>Aridogan</surname> <given-names>BC</given-names></name>. <article-title>Infection with Chlamydia pneumoniae but not Helicobacter pylori is related to elevated apolipoprotein B levels</article-title>. <source>Acta Cardiol</source>. <year>2005</year>;<volume>60</volume>: <fpage>599</fpage>–<lpage>604</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2143/AC.60.6.2004930" xlink:type="simple">10.2143/AC.60.6.2004930</ext-link></comment> <object-id pub-id-type="pmid">16385920</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chmiela</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Gajewski</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Rudnicka</surname> <given-names>K</given-names></name>. <article-title>Helicobacter pylori vs coronary heart disease—searching for connections</article-title>. <source>World J Cardiol</source>. <year>2015</year>;<volume>7</volume>: <fpage>187</fpage>–<lpage>203</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.4330/wjc.v7.i4.187" xlink:type="simple">10.4330/wjc.v7.i4.187</ext-link></comment> <object-id pub-id-type="pmid">25914788</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref037"><label>37</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mendall</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Goggin</surname> <given-names>PM</given-names></name>, <name name-style="western"><surname>Molineaux</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Levy</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Toosy</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Strachan</surname> <given-names>D</given-names></name>, <etal>et al</etal>. <article-title>Relation of Helicobacter pylori infection and coronary heart disease</article-title>. <source>Br Heart J</source>. <year>1994</year>;<volume>71</volume>: <fpage>437</fpage>–<lpage>439</lpage>. <object-id pub-id-type="pmid">8011406</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref038"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Libby</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Ridker</surname> <given-names>PM</given-names></name>, <name name-style="western"><surname>Hansson</surname> <given-names>GK</given-names></name>. <article-title>Progress and challenges in translating the biology of atherosclerosis</article-title>. <source>Nature</source>. <year>2011</year>;<volume>473</volume>: <fpage>317</fpage>–<lpage>325</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature10146" xlink:type="simple">10.1038/nature10146</ext-link></comment> <object-id pub-id-type="pmid">21593864</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref039"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mete</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Oran</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Alpsoy</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Gunes</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Tulubas</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Turan</surname> <given-names>C</given-names></name>, <etal>et al</etal>. <article-title>Carotid intima-media thickness and serum paraoxonase-1 activity in patients with Helicobacter pylori</article-title>. <source>Eur Rev Med Pharmacol Sci</source>. <year>2013</year>;<volume>17</volume>: <fpage>2884</fpage>–<lpage>2889</lpage>. <object-id pub-id-type="pmid">24254556</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref040"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mayr</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Kiechl</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Mendall</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Willeit</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Wick</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Xu</surname> <given-names>Q</given-names></name>. <article-title>Increased risk of atherosclerosis is confined to CagA-positive Helicobacter pylori strains: prospective results from the Bruneck study</article-title>. <source>Stroke</source>. <year>2003</year>;<volume>34</volume>: <fpage>610</fpage>–<lpage>615</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1161/01.STR.0000058481.82639.EF" xlink:type="simple">10.1161/01.STR.0000058481.82639.EF</ext-link></comment> <object-id pub-id-type="pmid">12624280</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref041"><label>41</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bao-Ge</surname> <given-names>Q</given-names></name>, <name name-style="western"><surname>Hui</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Yi-Guo</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Ji-Liang</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Zhong-Dong</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Ya-Fei</surname> <given-names>W</given-names></name>, <etal>et al</etal>. <article-title>The Correlation and Risk Factors between Carotid Intima-Media Thickening and Alcoholic Liver Disease Coupled with Helicobacter pylori Infection</article-title>. <source>Sci Rep</source>. <year>2017</year>;<volume>7</volume>: <fpage>43059</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/srep43059" xlink:type="simple">10.1038/srep43059</ext-link></comment> <object-id pub-id-type="pmid">28220866</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref042"><label>42</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Niemela</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Karttunen</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Korhonen</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Laara</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Karttunen</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Ikaheimo</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations?</article-title> <source>Heart</source>. <year>1996</year>;<volume>75</volume>: <fpage>573</fpage>–<lpage>575</lpage>. <object-id pub-id-type="pmid">8697159</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref043"><label>43</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Laurila</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Bloigu</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Nayha</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Hassi</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Leinonen</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Saikku</surname> <given-names>P</given-names></name>. <article-title>Association of Helicobacter pylori infection with elevated serum lipids</article-title>. <source>Atherosclerosis</source>. <year>1999</year>;<volume>142</volume>: <fpage>207</fpage>–<lpage>210</lpage>. <object-id pub-id-type="pmid">9920523</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref044"><label>44</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pohjanen</surname> <given-names>VM</given-names></name>, <name name-style="western"><surname>Koivurova</surname> <given-names>OP</given-names></name>, <name name-style="western"><surname>Niemela</surname> <given-names>SE</given-names></name>, <name name-style="western"><surname>Karttunen</surname> <given-names>RA</given-names></name>, <name name-style="western"><surname>Karttunen</surname> <given-names>TJ</given-names></name>. <article-title>Role of Helicobacter pylori and interleukin 6–174 gene polymorphism in dyslipidemia: a case-control study</article-title>. <source>BMJ Open</source>. <year>2016</year>;<volume>6</volume>: <fpage>e009987</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/bmjopen-2015-009987" xlink:type="simple">10.1136/bmjopen-2015-009987</ext-link></comment> <object-id pub-id-type="pmid">26781506</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref045"><label>45</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chen</surname> <given-names>LW</given-names></name>, <name name-style="western"><surname>Chien</surname> <given-names>CY</given-names></name>, <name name-style="western"><surname>Hsieh</surname> <given-names>CW</given-names></name>, <name name-style="western"><surname>Chang</surname> <given-names>LC</given-names></name>, <name name-style="western"><surname>Huang</surname> <given-names>MH</given-names></name>, <name name-style="western"><surname>Huang</surname> <given-names>WY</given-names></name>, <etal>et al</etal>. <article-title>The Associations Between Helicobacter pylori Infection, Serum Vitamin D, and Metabolic Syndrome: A Community-Based Study</article-title>. <source>Medicine (Baltimore)</source>. <year>2016</year>;<volume>95</volume>: <fpage>e3616</fpage>.</mixed-citation></ref>
<ref id="pone.0193646.ref046"><label>46</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Makoveichuk</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Vorrsjo</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Olivecrona</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Olivecrona</surname> <given-names>G</given-names></name>. <article-title>TNF-alpha decreases lipoprotein lipase activity in 3T3-L1 adipocytes by up-regulation of angiopoietin-like protein 4</article-title>. <source>Biochim Biophys Acta</source>. <year>2017</year>;<volume>1862</volume>: <fpage>533</fpage>–<lpage>540</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.bbalip.2017.02.005" xlink:type="simple">10.1016/j.bbalip.2017.02.005</ext-link></comment> <object-id pub-id-type="pmid">28215713</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref047"><label>47</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sheu</surname> <given-names>WHH</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>WJ</given-names></name>, <name name-style="western"><surname>Chang</surname> <given-names>RL</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>YT</given-names></name>. <article-title>Plasma tumor necrosis factor alpha levels and insulin sensitivity in hypertensive subjects</article-title>. <source>Clin Exp Hypertens</source>. <year>2000</year>;<volume>22</volume>: <fpage>595</fpage>–<lpage>606</lpage>. <object-id pub-id-type="pmid">10972164</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref048"><label>48</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tobin</surname> <given-names>NP</given-names></name>, <name name-style="western"><surname>Henehan</surname> <given-names>GT</given-names></name>, <name name-style="western"><surname>Murphy</surname> <given-names>RP</given-names></name>, <name name-style="western"><surname>Atherton</surname> <given-names>JC</given-names></name>, <name name-style="western"><surname>Guinan</surname> <given-names>AF</given-names></name>, <name name-style="western"><surname>Kerrigan</surname> <given-names>SW</given-names></name>, <etal>et al</etal>. <article-title>Helicobacter pylori-induced inhibition of vascular endothelial cell functions: a role for VacA-dependent nitric oxide reduction</article-title>. <source>Am J Physiol Heart Circ Physiol</source>. <year>2008</year>;<volume>295</volume>: <fpage>H1403</fpage>–<lpage>1413</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/ajpheart.00240.2008" xlink:type="simple">10.1152/ajpheart.00240.2008</ext-link></comment> <object-id pub-id-type="pmid">18660451</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref049"><label>49</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Diomedi</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Stanzione</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Sallustio</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Leone</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Renna</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Misaggi</surname> <given-names>G</given-names></name>, <etal>et al</etal>. <article-title>Cytotoxin-associated Gene-A-positive Helicobacter pylori strains infection increases the risk of recurrent atherosclerotic stroke</article-title>. <source>Helicobacter</source>. <year>2008</year>;<volume>13</volume>: <fpage>525</fpage>–<lpage>531</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1523-5378.2008.00627.x" xlink:type="simple">10.1111/j.1523-5378.2008.00627.x</ext-link></comment> <object-id pub-id-type="pmid">19166418</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref050"><label>50</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Okada</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Ayada</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Usui</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Yokota</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Cui</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Kawahara</surname> <given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>Antibodies against heat shock protein 60 derived from Helicobacter pylori: diagnostic implications in cardiovascular disease</article-title>. <source>J Autoimmun</source>. <year>2007</year>;<volume>29</volume>: <fpage>106</fpage>–<lpage>115</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jaut.2007.05.004" xlink:type="simple">10.1016/j.jaut.2007.05.004</ext-link></comment> <object-id pub-id-type="pmid">17606364</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref051"><label>51</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nakagawa</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Tamura</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Mitsuda</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Goto</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Kamiya</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Kondo</surname> <given-names>T</given-names></name>, <etal>et al</etal>. <article-title>Significant association between serum interleukin-6 and Helicobacter pylori antibody levels among H. pylori-positive Japanese adults</article-title>. <source>Mediators Inflamm</source>. <year>2013</year>;<volume>2013</volume>: <fpage>142358</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1155/2013/142358" xlink:type="simple">10.1155/2013/142358</ext-link></comment> <object-id pub-id-type="pmid">24453409</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref052"><label>52</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nazligul</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Aslan</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Horoz</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Celik</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Dulger</surname> <given-names>AC</given-names></name>, <name name-style="western"><surname>Celik</surname> <given-names>H</given-names></name>, <etal>et al</etal>. <article-title>The effect on serum myeloperoxidase activity and oxidative status of eradication treatment in patients Helicobacter pylori infected</article-title>. <source>Clin Biochem</source>. <year>2011</year>;<volume>44</volume>: <fpage>647</fpage>–<lpage>649</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.clinbiochem.2011.03.001" xlink:type="simple">10.1016/j.clinbiochem.2011.03.001</ext-link></comment> <object-id pub-id-type="pmid">21396358</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref053"><label>53</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zuin</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Rigatelli</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Del Favero</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Picariello</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Meggiato</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Conte</surname> <given-names>L</given-names></name>, <etal>et al</etal>. <article-title>Coronary artery disease and Helicobacter pylori infection: Should we consider eradication therapy as cardiovascular prevention strategy?</article-title> <source>Int J Cardiol</source>. <year>2016</year>;<volume>223</volume>: <fpage>711</fpage>–<lpage>712</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ijcard.2016.08.320" xlink:type="simple">10.1016/j.ijcard.2016.08.320</ext-link></comment> <object-id pub-id-type="pmid">27573593</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref054"><label>54</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Budoff</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Georgiou</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Brody</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Agatston</surname> <given-names>AS</given-names></name>, <name name-style="western"><surname>Kennedy</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Wolfkiel</surname> <given-names>C</given-names></name>, <etal>et al</etal>. <article-title>Ultrafast computed tomography as a diagnostic modality in the detection of coronary artery disease: a multicenter study</article-title>. <source>Circulation</source>. <year>1996</year>;<volume>93</volume>: <fpage>898</fpage>–<lpage>904</lpage>. <object-id pub-id-type="pmid">8598080</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref055"><label>55</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Haberl</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Becker</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Leber</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Knez</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Becker</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Lang</surname> <given-names>C</given-names></name>, <etal>et al</etal>. <article-title>Correlation of coronary calcification and angiographically documented stenoses in patients with suspected coronary artery disease: results of 1,764 patients</article-title>. <source>J Am Coll Cardiol</source>. <year>2001</year>;<volume>37</volume>: <fpage>451</fpage>–<lpage>457</lpage>. <object-id pub-id-type="pmid">11216962</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref056"><label>56</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ohnishi</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Fukui</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Ishikawa</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Ohnishi</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Ishigami</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Yoshioka</surname> <given-names>K</given-names></name>, <etal>et al</etal>. <article-title>Helicobacter pylori infection and arterial stiffness in patients with type 2 diabetes mellitus</article-title>. <source>Metabolism</source>. <year>2008</year>;<volume>57</volume>: <fpage>1760</fpage>–<lpage>1764</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.metabol.2008.08.001" xlink:type="simple">10.1016/j.metabol.2008.08.001</ext-link></comment> <object-id pub-id-type="pmid">19013302</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref057"><label>57</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Adachi</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Arima</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Takashima</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Miyaoka</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Yuki</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Ono</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Pulse-wave velocity and cardiovascular risk factors in subjects with Helicobacter pylori infection</article-title>. <source>J Gastroenterol Hepatol</source>. <year>2003</year>;<volume>18</volume>: <fpage>771</fpage>–<lpage>777</lpage>. <object-id pub-id-type="pmid">12795747</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref058"><label>58</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Budzynski</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Wisniewska</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Ciecierski</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Kedzia</surname> <given-names>A</given-names></name>. <article-title>Association between Bacterial Infection and Peripheral Vascular Disease: A Review</article-title>. <source>Int J Angiol</source>. <year>2016</year>;<volume>25</volume>: <fpage>3</fpage>–<lpage>13</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1055/s-0035-1547385" xlink:type="simple">10.1055/s-0035-1547385</ext-link></comment> <object-id pub-id-type="pmid">26900306</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref059"><label>59</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kowalski</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Rees</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Konturek</surname> <given-names>PC</given-names></name>, <name name-style="western"><surname>Grove</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Scheffold</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Meixner</surname> <given-names>H</given-names></name>, <etal>et al</etal>. <article-title>Detection of Helicobacter pylori specific DNA in human atheromatous coronary arteries and its association to prior myocardial infarction and unstable angina</article-title>. <source>Dig Liver Dis</source>. <year>2002</year>;<volume>34</volume>: <fpage>398</fpage>–<lpage>402</lpage>. <object-id pub-id-type="pmid">12132786</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref060"><label>60</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Farsak</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Yildirir</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Akyon</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Pinar</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Oc</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Boke</surname> <given-names>E</given-names></name>, <etal>et al</etal>. <article-title>Detection of Chlamydia pneumoniae and Helicobacter pylori DNA in human atherosclerotic plaques by PCR</article-title>. <source>J Clin Microbiol</source>. <year>2000</year>;<volume>38</volume>: <fpage>4408</fpage>–<lpage>4411</lpage>. <object-id pub-id-type="pmid">11101572</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref061"><label>61</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Crabtree</surname> <given-names>JE</given-names></name>, <name name-style="western"><surname>Kersulyte</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>SD</given-names></name>, <name name-style="western"><surname>Lindley</surname> <given-names>IJ</given-names></name>, <name name-style="western"><surname>Berg</surname> <given-names>DE</given-names></name>. <article-title>Modulation of Helicobacter pylori induced interleukin-8 synthesis in gastric epithelial cells mediated by cag PAI encoded VirD4 homologue</article-title>. <source>J Clin Pathol</source>. <year>1999</year>;<volume>52</volume>: <fpage>653</fpage>–<lpage>657</lpage>. <object-id pub-id-type="pmid">10655985</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref062"><label>62</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Huang</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Xie</surname> <given-names>Q</given-names></name>, <name name-style="western"><surname>Lin</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Feng</surname> <given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>CagA-positive Helicobacter pylori strains enhanced coronary atherosclerosis by increasing serum OxLDL and HsCRP in patients with coronary heart disease</article-title>. <source>Dig Dis Sci</source>. <year>2011</year>;<volume>56</volume>: <fpage>109</fpage>–<lpage>114</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s10620-010-1274-6" xlink:type="simple">10.1007/s10620-010-1274-6</ext-link></comment> <object-id pub-id-type="pmid">20503072</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref063"><label>63</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Franceschi</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Niccoli</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Ferrante</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Gasbarrini</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Baldi</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Candelli</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>CagA antigen of Helicobacter pylori and coronary instability: insight from a clinico-pathological study and a meta-analysis of 4241 cases</article-title>. <source>Atherosclerosis</source>. <year>2009</year>;<volume>202</volume>: <fpage>535</fpage>–<lpage>542</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.atherosclerosis.2008.04.051" xlink:type="simple">10.1016/j.atherosclerosis.2008.04.051</ext-link></comment> <object-id pub-id-type="pmid">18599062</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref064"><label>64</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kim</surname> <given-names>DW</given-names></name>, <name name-style="western"><surname>Park</surname> <given-names>JC</given-names></name>, <name name-style="western"><surname>Rim</surname> <given-names>TT</given-names></name>, <name name-style="western"><surname>Jung</surname> <given-names>UW</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>CS</given-names></name>, <name name-style="western"><surname>Donos</surname> <given-names>N</given-names></name>, <etal>et al</etal>. <article-title>Socioeconomic disparities of periodontitis in Koreans based on the KNHANES IV</article-title>. <source>Oral Dis</source>. <year>2014</year>;<volume>20</volume>: <fpage>551</fpage>–<lpage>559</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/odi.12168" xlink:type="simple">10.1111/odi.12168</ext-link></comment> <object-id pub-id-type="pmid">24033864</object-id></mixed-citation></ref>
<ref id="pone.0193646.ref065"><label>65</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kim</surname> <given-names>SK</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Kang</surname> <given-names>HT</given-names></name>, <name name-style="western"><surname>Oh</surname> <given-names>SS</given-names></name>, <name name-style="western"><surname>Ko</surname> <given-names>SB</given-names></name>. <article-title>The Relationship between Injury and Socioeconomic Status in Reference to the Fourth Korean National Health and Nutrition Examination Survey</article-title>. <source>Ann Occup Environ Med</source>. <year>2014</year>;<volume>26</volume>: <fpage>1</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/2052-4374-26-1" xlink:type="simple">10.1186/2052-4374-26-1</ext-link></comment> <object-id pub-id-type="pmid">24472308</object-id></mixed-citation></ref>
</ref-list>
</back>
</article>